Article Data

  • Views 231
  • Dowloads 154

Original Research

Open Access

GLUT1-mediated magnetic liposomes for targeting bone metastatic breast cancer

  • Ze Zhao1,*,
  • Yi Zhao2,*,
  • Changqing Chen1
  • Changwei Xie1

1Department of Orthopedics, the First Affiliated Hospital of Henan Polytechnic University (the Second People's Hospital of Jiaozuo City), 454001 Jiaozuo, Henan, China

2Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, China

DOI: 10.22514/ejgo.2023.012 Vol.44,Issue 1,February 2023 pp.98-105

Submitted: 23 September 2022 Accepted: 30 November 2022

Published: 15 February 2023

*Corresponding Author(s): Ze Zhao E-mail:
*Corresponding Author(s): Yi Zhao E-mail:


Bone metastatic breast cancer is a malignant tumor in bone due to the metastasis of breast cancer, and its incidence is increasing worldwide. Treatment of cancer metastasized to bone is still a challenge because of the anticancer drugs lack target specificity. Finding an effective treatment for bone metastasis remains an urgent issue. In order to enhance the delivery of paclitaxel (PTX) to the bone metastases lesions, a novel glucose derivative was designed and synthesized in this work, which was used as liposome ligand to develop the magnetic liposome G-MLip (Glucose-modified magnetic liposome). The liposome could improve the drug formulations in the bone metastases mediated by glucose transporter 1 (GLUT1) and then target cancer cells. The PTX-loaded magnetic liposome PTX-G-MLip was prepared by the film hydration-ultrasound method. And the characterizations, such as size, zeta potential, encapsulation efficiency, release profile, stability, hemolysis, were well evaluated. What’s more, the enhanced target ability was also investigated in vitro and in mice. The metastatic bone-targeted capacity was confirmed that the PTX concentration from PTX-G-MLip in the bone metastases lesions was markedly increased in the presence of magnetic field (MF) compared with the free PTX and other liposomes. Inspired by the enhanced targeting ability, glucose-modified magnetic liposomes could serve as an effective drug delivery system for targeting and treating bone metastases.


Bone metastases; GLUT1; Magnetic liposomes; Warburg effect

Cite and Share

Ze Zhao,Yi Zhao,Changqing Chen,Changwei Xie. GLUT1-mediated magnetic liposomes for targeting bone metastatic breast cancer. European Journal of Gynaecological Oncology. 2023. 44(1);98-105.


[1] Verbruggen ASK, McCarthy EC, Dwyer RM, McNamara LM. Temporal and spatial changes in bone mineral content and mechanical properties during breast-cancer bone metastases. Bone Reports. 2022; 17: 101597.

[2] Zhao Z, Zhao Y, Xie C, Chen C, Lin D, Wang S, et al. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation. Chemistry and Physics of Lipids. 2019; 223: 104785.

[3] Luo B, Yuan Y, Zhu Y, Liang S, Dong R, Hou J, et al. microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition. Frontiers in Oncology. 2022; 12: 988794.

[4] Isik A, Soran A, Grasi A, Barry N, Sezgin E. Lymphedema after sentinel lymph node biopsy: who is at risk? Lymphatic Research and Biology. 2022; 20: 160–163.

[5] Işık A, Grassi A, Soran A. Positive axilla in breast cancer; clinical practice in 2018. European Journal of Breast Health. 2018; 14: 134–135.

[6] Yang Y, Zhao Z, Xie C, Zhao Y. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer. Chemistry and Physics of Lipids. 2020; 228: 104882.

[7] Zhang X, Liu Q, Zhang T, Gao P, Wang H, Yao L, et al. Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment. Drug Delivery. 2022; 29: 889––905.

[8] Hendriks LE, Hermans BC, van den Beuken-van Everdingen MH, Hochstenbag MM, Dingemans AM. Effect of bisphosphonates, denosumab, and radioisotopes on bone pain and quality of life in patients with non-small cell lung cancer and bone metastases: a systematic review. Journal of Thoracic Oncology. 2016; 11: 155–173.

[9] Zhao Z, Chen C, Xie C, Zhao Y. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting. Chemistry and Physics of Lipids. 2020; 226: 104832.

[10] Mu X, Zhang M, Wei A, Yin F, Wang Y, Hu K, et al. Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases. Nanoscale. 2021; 13: 8998–9008.

[11] Shao H Shao H, Varamini P. Breast cancer bone metastasis: a narrative review of emerging targeted drug delivery systems. Cells. 2022; 11: 388.

[12] Bose S, Zhang C, Le A. Glucose metabolism in cancer: the warburg effect and beyond. Advances in Experimental Medicine and Biology. 2021; 1311: 3–15.

[13] Zhao Y, Peng Y, Yang Z, Lu J, Li R, Shi Y, et al. PH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma. European Journal of Medicinal Chemistry. 2022; 235: 114281.

[14] Zhao Y, Zhao Z, Cui Y, Chen X, Chen C, Xie C, et al. Redox-responsive glycosylated combretastatin A-4 derivative as novel tubulin polymerization inhibitor for glioma and drug delivery. Drug Development Research. 2021; 82: 1063–1072.

[15] Siyal FJ, Memon Z, Siddiqui RA, Aslam Z, Nisar U, Imad R, et al. Eugenol and liposome-based nanocarriers loaded with eugenol protect against anxiolytic disorder via down regulation of neurokinin-1 receptors in mice. Pakistan Journal of Pharmaceutical Sciences. 2020; 33: 2275–2284.

[16] Han B, Yang Y, Chen J, Tang H, Sun Y, Zhang Z, et al. Preparation, characterization, and pharmacokinetic study of a novel long-acting targeted paclitaxel liposome with antitumor activity. International Journal of Nanomedicine. 2020; 15: 553–571.

[17] Chen R, Chen X, Zhou Y, Lin T, Leng Y, Huang X, et al. “Three-in-one” multifunctional nanohybrids with colorimetric magnetic catalytic activities to enhance immunochromatographic diagnosis. ACS Nano. 2022; 16: 3351–3361.

[18] Peng Y, Gao Y, Yang C, Guo R, Shi X, Cao X. Low-molecular-weight poly(ethylenimine) nanogels loaded with ultrasmall iron oxide nanoparticles for T_1-weighted MR imaging-guided gene therapy of sarcoma. ACS Applied Materials & Interfaces. 2021; 13: 27806–27813.

[19] Zhang L, Zhao Y, Yue Q, Fu Q, Hai L, Guo L, et al. Preparation and characterization of GLUT1-mediated novel brain targeting magnetic nanoparticles. Letters in Drug Design & Discovery. 2018; 15: 1308–1313.

[20] Zhu M, Liu X, Qu Y, Hu S, Zhang Y, Li W, et al. Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis. Journal of Bone Oncology. 2019; 15: 100219.

[21] Kim JW, Lee S, Kim HS, Choi YJ, Yoo J, Park KU, et al. Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10–13). Cytokine. 2021; 142: 155487.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time